Exploiting new knowledge of Candidal infection for future antifungal combat

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Exploiting new knowledge of Candidal infection for future antifungal combat. / Kragelund, Camilla.

I: Oral Diseases, Bind 23, Nr. 5, 2017, s. 543-547.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Kragelund, C 2017, 'Exploiting new knowledge of Candidal infection for future antifungal combat', Oral Diseases, bind 23, nr. 5, s. 543-547. https://doi.org/10.1111/odi.12546

APA

Kragelund, C. (2017). Exploiting new knowledge of Candidal infection for future antifungal combat. Oral Diseases, 23(5), 543-547. https://doi.org/10.1111/odi.12546

Vancouver

Kragelund C. Exploiting new knowledge of Candidal infection for future antifungal combat. Oral Diseases. 2017;23(5):543-547. https://doi.org/10.1111/odi.12546

Author

Kragelund, Camilla. / Exploiting new knowledge of Candidal infection for future antifungal combat. I: Oral Diseases. 2017 ; Bind 23, Nr. 5. s. 543-547.

Bibtex

@article{3470f6ee92694c15b7052f901aec42ab,
title = "Exploiting new knowledge of Candidal infection for future antifungal combat",
abstract = "During recent years in vitro and animal studies have contributed significantly to the knowledge of Candida virulence mechanisms and identification of potential targets for new antifungal treatment. Candida infection is seen as a significant problem for human health in the future in particular in immunocompromised patients (World Health Organization, 2014). In 2013 fluconazole-resistant Candida was listed as having equivalent threat level to human health as Methicillin-resistant Staphylococcus aureus (MRSA) by the Centers for Disease Control and Prevention (CDC) of the U.S. This article is protected by copyright. All rights reserved.",
author = "Camilla Kragelund",
note = "This article is protected by copyright. All rights reserved.",
year = "2017",
doi = "10.1111/odi.12546",
language = "English",
volume = "23",
pages = "543--547",
journal = "Oral Diseases",
issn = "1354-523X",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - Exploiting new knowledge of Candidal infection for future antifungal combat

AU - Kragelund, Camilla

N1 - This article is protected by copyright. All rights reserved.

PY - 2017

Y1 - 2017

N2 - During recent years in vitro and animal studies have contributed significantly to the knowledge of Candida virulence mechanisms and identification of potential targets for new antifungal treatment. Candida infection is seen as a significant problem for human health in the future in particular in immunocompromised patients (World Health Organization, 2014). In 2013 fluconazole-resistant Candida was listed as having equivalent threat level to human health as Methicillin-resistant Staphylococcus aureus (MRSA) by the Centers for Disease Control and Prevention (CDC) of the U.S. This article is protected by copyright. All rights reserved.

AB - During recent years in vitro and animal studies have contributed significantly to the knowledge of Candida virulence mechanisms and identification of potential targets for new antifungal treatment. Candida infection is seen as a significant problem for human health in the future in particular in immunocompromised patients (World Health Organization, 2014). In 2013 fluconazole-resistant Candida was listed as having equivalent threat level to human health as Methicillin-resistant Staphylococcus aureus (MRSA) by the Centers for Disease Control and Prevention (CDC) of the U.S. This article is protected by copyright. All rights reserved.

U2 - 10.1111/odi.12546

DO - 10.1111/odi.12546

M3 - Journal article

C2 - 27442140

VL - 23

SP - 543

EP - 547

JO - Oral Diseases

JF - Oral Diseases

SN - 1354-523X

IS - 5

ER -

ID: 164439393